Botulinum neurotoxins (BoNTs) are the most toxic proteins currently known. Current treatments for botulinum poisoning are all protein based with a limited window of opportunity. Inhibition of the BoNT light chain protease (LC) has emerged as a new therapeutic strategy for the treatment of botulism as it may provide an effective post-exposure remedy. As such, a small library of 40 betulin derivatives was synthesized and screened against the light chain of BoNT serotype A (LC/A); five positive hits (IC50 <100 μM) were uncovered. Detailed evaluation of inhibition mechanism of three most active compounds revealed a competitive model, with sub-micromolar Ki value for the best inhibitor (7). Unfortunately, an in vitro cell-based assay did not show any protection of rat cerebellar neurons against BoNT/A intoxication by 7.
- betulin derivatives
- botulinum neurotoxin
- protease inhibitor
Silhár, P., Alakurtti, S., Capková, K., Xiaochuan, F., Shoemaker, C. B., Yli-Kauhaluoma, J., & Janda, K. D. (2011). Synthesis and evaluation of library of betulin derivatives against the botulinum neurotoxin A protease. Bioorganic and Medicinal Chemistry Letters, 21(8), 2229-2231. https://doi.org/10.1016/j.bmcl.2011.02.115